Impaired absorption of insulin aspart from lipohypertrophic injection sites

[1] Alemzadeh Ramin, 2003, Diabetes Technol Ther, V5, P167, DOI 10.1089/152091503321827821

[2] ARNQVIST H, 1987, CLIN CHEM, V33, P93

[3] ABSORPTION KINETICS OF SUBCUTANEOUSLY INJECTED INSULIN - EVIDENCE FOR DEGRADATION AT THE INJECTION SITE [J]. DIABETOLOGIA, 1979, 17 (02) : 97 - 99

[4] Lesson of the week - Poor glycaemic control caused by insulin induced lipohypertrophy [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7411): : 383 - 384

[5] CLINICALLY IMPORTANT DIFFERENCES IN INSULIN ABSORPTION FROM ABDOMEN IN IDDM [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 21 (2-3) : 137 - 141

[6] Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (02) : 106 - 110

[7] Ibarra LS -D, 1998, PRACT DIABETES INT, V15, P9, DOI DOI 10.1002/PDI.1960150108

[8] Lipohypertrophy in young patients with type 1 diabetes [J]. DIABETES CARE, 2002, 25 (03) : 634 - 634

[9] Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs [J]. DIABETES CARE, 2002, 25 (06) : 1049 - 1054

[10] REACH G, 1993, DIABETES METAB, V19, P195

[1] Alemzadeh Ramin, 2003, Diabetes Technol Ther, V5, P167, DOI 10.1089/152091503321827821

[2] ARNQVIST H, 1987, CLIN CHEM, V33, P93

[3] ABSORPTION KINETICS OF SUBCUTANEOUSLY INJECTED INSULIN - EVIDENCE FOR DEGRADATION AT THE INJECTION SITE [J]. DIABETOLOGIA, 1979, 17 (02) : 97 - 99

[4] Lesson of the week - Poor glycaemic control caused by insulin induced lipohypertrophy [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7411): : 383 - 384

[5] CLINICALLY IMPORTANT DIFFERENCES IN INSULIN ABSORPTION FROM ABDOMEN IN IDDM [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 21 (2-3) : 137 - 141

[6] Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (02) : 106 - 110

[7] Ibarra LS -D, 1998, PRACT DIABETES INT, V15, P9, DOI DOI 10.1002/PDI.1960150108

[8] Lipohypertrophy in young patients with type 1 diabetes [J]. DIABETES CARE, 2002, 25 (03) : 634 - 634

[9] Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs [J]. DIABETES CARE, 2002, 25 (06) : 1049 - 1054

[10] REACH G, 1993, DIABETES METAB, V19, P195